AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Orchestra BioMed Holdings, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Orchestra BioMed Holdings (OBIO) reported insider trading activity through a Form 4 filing for Director David Pacitti. On June 24, 2025, Pacitti received two equity compensation awards:

  • 12,422 Restricted Stock Units (RSUs) with a $0 exercise price, bringing his direct ownership to 29,968 shares
  • 36,797 Stock Options with an exercise price of $3.22 per share, expiring June 24, 2035

Both the RSUs and stock options will vest in a single installment at the earlier of: (1) one-year anniversary of the grant date, or (2) the company's 2026 Annual Meeting of Stockholders, subject to continued service. This equity compensation aligns the director's interests with shareholders through a combination of full-value shares and performance incentives.

Orchestra BioMed Holdings (OBIO) ha comunicato un'attività di insider trading tramite una dichiarazione Form 4 per il Direttore David Pacitti. Il 24 giugno 2025, Pacitti ha ricevuto due premi di compensazione azionaria:

  • 12.422 Unità Azionarie Vincolate (RSU) con prezzo di esercizio pari a $0, portando la sua proprietà diretta a 29.968 azioni
  • 36.797 Opzioni Su Azioni con prezzo di esercizio di $3,22 per azione, in scadenza il 24 giugno 2035

Sia le RSU che le opzioni azionarie matureranno in un'unica tranche al verificarsi del primo tra: (1) il primo anniversario della data di assegnazione, o (2) l’Assemblea Annuale degli Azionisti 2026 della società, subordinatamente al mantenimento del rapporto di lavoro. Questa forma di compensazione azionaria allinea gli interessi del direttore con quelli degli azionisti attraverso una combinazione di azioni a valore pieno e incentivi legati alle performance.

Orchestra BioMed Holdings (OBIO) reportó actividad de operaciones internas mediante una presentación del Formulario 4 para el Director David Pacitti. El 24 de junio de 2025, Pacitti recibió dos premios de compensación en acciones:

  • 12,422 Unidades de Acciones Restringidas (RSUs) con un precio de ejercicio de $0, aumentando su propiedad directa a 29,968 acciones
  • 36,797 Opciones sobre Acciones con un precio de ejercicio de $3.22 por acción, que expiran el 24 de junio de 2035

Tanto las RSUs como las opciones sobre acciones se consolidarán en un solo pago en la fecha que ocurra primero entre: (1) el primer aniversario de la fecha de concesión, o (2) la Junta Anual de Accionistas 2026 de la compañía, sujeto a la continuidad del servicio. Esta compensación en acciones alinea los intereses del director con los de los accionistas mediante una combinación de acciones de valor completo e incentivos por desempeño.

Orchestra BioMed Holdings (OBIO)ëŠ� ì´ì‚¬ David Pacittiì—� 대í•� ë‚´ë¶€ìž� 거래 활ë™ì� Form 4 제출ì� 통해 보고했습니다. 2025ë…� 6ì›� 24ì�, PacittiëŠ� ë‘� 가지 ì£¼ì‹ ë³´ìƒ ìˆ˜ì—¬ë¥� 받았습니ë‹�:

  • 12,422 제한 ì£¼ì‹ ë‹¨ìœ„(RSU)ë¡� í–‰ì‚¬ê°€ê²©ì€ $0ì´ë©°, ê·¸ì˜ ì§ì ‘ 소유 주ì‹ì€ 29,968주가 ë˜ì—ˆìŠµë‹ˆë‹�
  • 36,797 ì£¼ì‹ ì˜µì…˜ìœ¼ë¡œ 주당 í–‰ì‚¬ê°€ê²©ì€ $3.22ì´ë©°, 만료ì¼ì€ 2035ë…� 6ì›� 24ì¼ìž…니다

RSU와 ì£¼ì‹ ì˜µì…˜ ëª¨ë‘ ë‹¤ìŒ ì¤� 빠른 시ì ì—� ë‹¨ì¼ í• ë¶€ë¡� 베스팅ë©ë‹ˆë‹¤: (1) 수여ì¼ë¡œë¶€í„� 1ë…� 기ë…ì�, ë˜ëŠ” (2) 회사ì� 2026ë…� ì—°ë¡€ 주주ì´íšŒ, ì§€ì†ì ì� 근무 ì¡°ê±´ 하ì—. ì� ì£¼ì‹ ë³´ìƒì€ ì „ì•¡ ê°€ì¹� 주ì‹ê³� 성과 ì¸ì„¼í‹°ë¸Œë¥� 결합하여 ì´ì‚¬ì� ì´í•´ê´€ê³„를 주주와 ì¼ì¹˜ì‹œí‚µë‹ˆë‹¤.

Orchestra BioMed Holdings (OBIO) a déclaré une activité d’initiés via un dépôt de formulaire 4 concernant le Directeur David Pacitti. Le 24 juin 2025, Pacitti a reçu deux attributions de rémunération en actions :

  • 12 422 unités d’actions restreintes (RSU) avec un prix d’exercice de 0 $, portant sa détention directe à 29 968 actions
  • 36 797 options d’achat d’actions avec un prix d’exercice de 3,22 $ par action, expirant le 24 juin 2035

Les RSU et les options d’achat d’actions seront acquises en une seule fois au premier des deux événements suivants : (1) l’anniversaire d’un an de la date d’attribution, ou (2) l’assemblée générale annuelle des actionnaires 2026, sous réserve de la poursuite du service. Cette rémunération en actions aligne les intérêts du directeur avec ceux des actionnaires grâce à une combinaison d’actions à pleine valeur et d’incitations à la performance.

Orchestra BioMed Holdings (OBIO) meldete Insiderhandelstätigkeiten durch eine Form 4 Einreichung für Direktor David Pacitti. Am 24. Juni 2025 erhielt Pacitti zwei Aktienvergütungszuteilungen:

  • 12.422 Restricted Stock Units (RSUs) mit einem Ausübungspreis von 0 $, wodurch sein Direktbesitz auf 29.968 Aktien anstieg
  • 36.797 Aktienoptionen mit einem Ausübungspreis von 3,22 $ pro Aktie, gültig bis zum 24. Juni 2035

Sowohl die RSUs als auch die Aktienoptionen werden in einer einzigen Tranche fällig, und zwar zu dem früheren Zeitpunkt von: (1) dem einjährigen Jubiläum des Gewährungsdatums oder (2) der Hauptversammlung 2026 des Unternehmens, vorbehaltlich fortgesetzter Dienstzeit. Diese Aktienvergütung richtet die Interessen des Direktors durch eine Kombination aus vollwertigen Aktien und leistungsabhängigen Anreizen mit denen der Aktionäre aus.

Positive
  • None.
Negative
  • None.

Orchestra BioMed Holdings (OBIO) ha comunicato un'attività di insider trading tramite una dichiarazione Form 4 per il Direttore David Pacitti. Il 24 giugno 2025, Pacitti ha ricevuto due premi di compensazione azionaria:

  • 12.422 Unità Azionarie Vincolate (RSU) con prezzo di esercizio pari a $0, portando la sua proprietà diretta a 29.968 azioni
  • 36.797 Opzioni Su Azioni con prezzo di esercizio di $3,22 per azione, in scadenza il 24 giugno 2035

Sia le RSU che le opzioni azionarie matureranno in un'unica tranche al verificarsi del primo tra: (1) il primo anniversario della data di assegnazione, o (2) l’Assemblea Annuale degli Azionisti 2026 della società, subordinatamente al mantenimento del rapporto di lavoro. Questa forma di compensazione azionaria allinea gli interessi del direttore con quelli degli azionisti attraverso una combinazione di azioni a valore pieno e incentivi legati alle performance.

Orchestra BioMed Holdings (OBIO) reportó actividad de operaciones internas mediante una presentación del Formulario 4 para el Director David Pacitti. El 24 de junio de 2025, Pacitti recibió dos premios de compensación en acciones:

  • 12,422 Unidades de Acciones Restringidas (RSUs) con un precio de ejercicio de $0, aumentando su propiedad directa a 29,968 acciones
  • 36,797 Opciones sobre Acciones con un precio de ejercicio de $3.22 por acción, que expiran el 24 de junio de 2035

Tanto las RSUs como las opciones sobre acciones se consolidarán en un solo pago en la fecha que ocurra primero entre: (1) el primer aniversario de la fecha de concesión, o (2) la Junta Anual de Accionistas 2026 de la compañía, sujeto a la continuidad del servicio. Esta compensación en acciones alinea los intereses del director con los de los accionistas mediante una combinación de acciones de valor completo e incentivos por desempeño.

Orchestra BioMed Holdings (OBIO)ëŠ� ì´ì‚¬ David Pacittiì—� 대í•� ë‚´ë¶€ìž� 거래 활ë™ì� Form 4 제출ì� 통해 보고했습니다. 2025ë…� 6ì›� 24ì�, PacittiëŠ� ë‘� 가지 ì£¼ì‹ ë³´ìƒ ìˆ˜ì—¬ë¥� 받았습니ë‹�:

  • 12,422 제한 ì£¼ì‹ ë‹¨ìœ„(RSU)ë¡� í–‰ì‚¬ê°€ê²©ì€ $0ì´ë©°, ê·¸ì˜ ì§ì ‘ 소유 주ì‹ì€ 29,968주가 ë˜ì—ˆìŠµë‹ˆë‹�
  • 36,797 ì£¼ì‹ ì˜µì…˜ìœ¼ë¡œ 주당 í–‰ì‚¬ê°€ê²©ì€ $3.22ì´ë©°, 만료ì¼ì€ 2035ë…� 6ì›� 24ì¼ìž…니다

RSU와 ì£¼ì‹ ì˜µì…˜ ëª¨ë‘ ë‹¤ìŒ ì¤� 빠른 시ì ì—� ë‹¨ì¼ í• ë¶€ë¡� 베스팅ë©ë‹ˆë‹¤: (1) 수여ì¼ë¡œë¶€í„� 1ë…� 기ë…ì�, ë˜ëŠ” (2) 회사ì� 2026ë…� ì—°ë¡€ 주주ì´íšŒ, ì§€ì†ì ì� 근무 ì¡°ê±´ 하ì—. ì� ì£¼ì‹ ë³´ìƒì€ ì „ì•¡ ê°€ì¹� 주ì‹ê³� 성과 ì¸ì„¼í‹°ë¸Œë¥� 결합하여 ì´ì‚¬ì� ì´í•´ê´€ê³„를 주주와 ì¼ì¹˜ì‹œí‚µë‹ˆë‹¤.

Orchestra BioMed Holdings (OBIO) a déclaré une activité d’initiés via un dépôt de formulaire 4 concernant le Directeur David Pacitti. Le 24 juin 2025, Pacitti a reçu deux attributions de rémunération en actions :

  • 12 422 unités d’actions restreintes (RSU) avec un prix d’exercice de 0 $, portant sa détention directe à 29 968 actions
  • 36 797 options d’achat d’actions avec un prix d’exercice de 3,22 $ par action, expirant le 24 juin 2035

Les RSU et les options d’achat d’actions seront acquises en une seule fois au premier des deux événements suivants : (1) l’anniversaire d’un an de la date d’attribution, ou (2) l’assemblée générale annuelle des actionnaires 2026, sous réserve de la poursuite du service. Cette rémunération en actions aligne les intérêts du directeur avec ceux des actionnaires grâce à une combinaison d’actions à pleine valeur et d’incitations à la performance.

Orchestra BioMed Holdings (OBIO) meldete Insiderhandelstätigkeiten durch eine Form 4 Einreichung für Direktor David Pacitti. Am 24. Juni 2025 erhielt Pacitti zwei Aktienvergütungszuteilungen:

  • 12.422 Restricted Stock Units (RSUs) mit einem Ausübungspreis von 0 $, wodurch sein Direktbesitz auf 29.968 Aktien anstieg
  • 36.797 Aktienoptionen mit einem Ausübungspreis von 3,22 $ pro Aktie, gültig bis zum 24. Juni 2035

Sowohl die RSUs als auch die Aktienoptionen werden in einer einzigen Tranche fällig, und zwar zu dem früheren Zeitpunkt von: (1) dem einjährigen Jubiläum des Gewährungsdatums oder (2) der Hauptversammlung 2026 des Unternehmens, vorbehaltlich fortgesetzter Dienstzeit. Diese Aktienvergütung richtet die Interessen des Direktors durch eine Kombination aus vollwertigen Aktien und leistungsabhängigen Anreizen mit denen der Aktionäre aus.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pacitti David

(Last) (First) (Middle)
C/O ORCHESTRA BIOMED HOLDINGS, INC.
150 UNION SQUARE DRIVE

(Street)
NEW HOPE PA 18938

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 per share ("Common Stock") 06/24/2025 A 12,422(1) A $0 29,968 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $3.22 06/24/2025 A 36,797 (2) 06/24/2035 Common Stock 36,797 $0 36,797 D
Explanation of Responses:
1. Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 24, 2025 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates.
2. The stock options will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates.
/s/ Andrew Taylor, Attorney-in-Fact 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What stock grants did OBIO director David Pacitti receive on June 24, 2025?

David Pacitti received two equity grants on June 24, 2025: (1) 12,422 restricted stock units (RSUs) and (2) stock options to purchase 36,797 shares of common stock at an exercise price of $3.22 per share.

When do David Pacitti's OBIO RSUs and stock options vest?

Both the RSUs and stock options will vest in one installment on the earlier of: (1) the one-year anniversary of the grant date (June 24, 2026) or (2) the date of OBIO's 2026 Annual Meeting of Stockholders, subject to continuous service.

How many shares of OBIO stock does David Pacitti own after the June 2025 grants?

Following the transactions, David Pacitti directly owns 29,968 shares of OBIO common stock and 36,797 stock options. The 12,422 RSUs will convert to common shares upon vesting.

What is the exercise price and expiration date of OBIO stock options granted to Pacitti?

The stock options were granted with an exercise price of $3.22 per share and expire on June 24, 2035, ten years from the grant date.
Orchestra BioMed Holdings Inc

NASDAQ:OBIO

OBIO Rankings

OBIO Latest News

OBIO Latest SEC Filings

OBIO Stock Data

119.54M
25.36M
21.82%
55.5%
1.39%
Biotechnology
Surgical & Medical Instruments & Apparatus
United States
NEW HOPE